Bohnen Shane's most recent trade in Bio-Techne Corp was a trade of 2,260 Common Stock done . Disclosure was reported to the exchange on April 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bio-Techne | Shane Bohnen | SVP - General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2025 | 2,260 | 3,941 (0%) | 0% | 0 | Common Stock | |
| Bio-Techne | Shane Bohnen | SVP - General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2025 | 2,260 | 2,259 | - | - | Restricted Stock Units | |
| Bio-Techne | Shane Bohnen | SVP - General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 54.86 per share. | 03 Apr 2025 | 747 | 3,194 (0%) | 0% | 54.9 | 40,980 | Common Stock |
| Bio-Techne | Shane Bohnen | SVP - General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2024 | 13,488 | 13,488 | - | - | Stock Option (Right to Buy) | |
| Bio-Techne | Shane Bohnen | SVP - General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2024 | 10,012 | 10,012 | - | - | Performance Restricted Stock Units | |
| Bio-Techne | Shane Bohnen | SVP - General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2024 | 5,006 | 5,006 | - | - | Restricted Stock Units | |
| Bio-Techne | Shane Bohnen | SVP - General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 49 | 1,696 (0%) | 0% | 0 | Common Stock | |
| Bio-Techne | Shane Bohnen | SVP - General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 49 | 99 | - | - | Restricted Stock Units | |
| Bio-Techne | Shane Bohnen | SVP - General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.93 per share. | 15 Aug 2024 | 15 | 1,681 (0%) | 0% | 74.9 | 1,124 | Common Stock |
| Bio-Techne | Shane Bohnen | SVP - General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2024 | 2,259 | 4,519 | - | - | Restricted Stock Units | |
| Bio-Techne | Shane Bohnen | SVP - General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2024 | 2,259 | 2,394 (0%) | 0% | - | Common Stock | |
| Bio-Techne | Shane Bohnen | SVP - General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 67.87 per share. | 03 Apr 2024 | 747 | 1,647 (0%) | 0% | 67.9 | 50,699 | Common Stock |
| Bio-Techne | Shane Bohnen | SVP - General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2023 | 16,302 | 16,302 | - | - | Stock Option (Right to Buy) | |
| Bio-Techne | Bohnen Shane | SVP - General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2023 | 12,924 | 12,924 | - | - | Stock Option (Right to Buy) | |
| Bio-Techne | Shane Bohnen | SVP - General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2023 | 4,802 | 4,802 | - | - | Restricted Stock Units | |
| Bio-Techne | Shane Bohnen | SVP - General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2023 | 148 | 148 | - | - | Restricted Stock Units | |
| Bio-Techne | Shane Bohnen | SVP - General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 6,778 | 6,778 | - | - | Restricted Stock Units | |
| Bio-Techne | Shane Bohnen | SVP - General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 3,928 | 3,928 | - | - | Stock Option (right to buy) |